Emibetuzumab

Tidak ditemukan merek terdaftar untuk zat aktif ini.

Tidak ada catatan makanan tercatat untuk zat aktif ini.

• AbciximabMODERAT

  Mengonsumsi Abciximab bersama Emibetuzumab dapat meningkatkan risiko atau keparahan efek samping.

  Tampilan ahli

  The risk or severity of adverse effects can be increased when Abciximab is combined with Emibetuzumab.

• AdalimumabMODERAT

  Mengonsumsi Adalimumab bersama Emibetuzumab dapat meningkatkan risiko atau keparahan efek samping.

  Tampilan ahli

  The risk or severity of adverse effects can be increased when Adalimumab is combined with Emibetuzumab.

• AdecatumumabMODERAT

  Mengonsumsi Adecatumumab bersama Emibetuzumab dapat meningkatkan risiko atau keparahan efek samping.

  Tampilan ahli

  The risk or severity of adverse effects can be increased when Adecatumumab is combined with Emibetuzumab.

• AfelimomabMODERAT

  Mengonsumsi Afelimomab bersama Emibetuzumab dapat meningkatkan risiko atau keparahan efek samping.

  Tampilan ahli

  The risk or severity of adverse effects can be increased when Afelimomab is combined with Emibetuzumab.

• AlemtuzumabMODERAT

  Mengonsumsi Alemtuzumab bersama Emibetuzumab dapat meningkatkan risiko atau keparahan efek samping.

  Tampilan ahli

  The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Emibetuzumab.

• AlirocumabMODERAT

  Mengonsumsi Alirocumab bersama Emibetuzumab dapat meningkatkan risiko atau keparahan efek samping.

  Tampilan ahli

  The risk or severity of adverse effects can be increased when Alirocumab is combined with Emibetuzumab.

• AMG 108MODERAT

  Mengonsumsi AMG 108 bersama Emibetuzumab dapat meningkatkan risiko atau keparahan efek samping.

  Tampilan ahli

  The risk or severity of adverse effects can be increased when AMG 108 is combined with Emibetuzumab.

• Anthrax immune globulin humanMODERAT

  Mengonsumsi Anthrax immune globulin human bersama Emibetuzumab dapat meningkatkan risiko atau keparahan efek samping.

  Tampilan ahli

  The risk or severity of adverse effects can be increased when Anthrax immune globulin human is combined with Emibetuzumab.

• Antilymphocyte immunoglobulin (horse)MODERAT

  Mengonsumsi Antilymphocyte immunoglobulin (horse) bersama Emibetuzumab dapat meningkatkan risiko atau keparahan efek samping.

  Tampilan ahli

  The risk or severity of adverse effects can be increased when Antilymphocyte immunoglobulin (horse) is combined with Emibetuzumab.

• Antithymocyte immunoglobulin (rabbit)MODERAT

  Mengonsumsi Antithymocyte immunoglobulin (rabbit) bersama Emibetuzumab dapat meningkatkan risiko atau keparahan efek samping.

  Tampilan ahli

  The risk or severity of adverse effects can be increased when Antithymocyte immunoglobulin (rabbit) is combined with Emibetuzumab.